Guy Bushkin serves as Principal Scientist at Ancilia Biosciences, where he leverages his extensive expertise in gene editing and strain engineering to drive innovative solutions in biotherapeutics. His current focus is on engineering non-model, transformation recalcitrant bacteria, a challenging endeavor that has significant implications for...
Guy Bushkin serves as Principal Scientist at Ancilia Biosciences, where he leverages his extensive expertise in gene editing and strain engineering to drive innovative solutions in biotherapeutics. His current focus is on engineering non-model, transformation recalcitrant bacteria, a challenging endeavor that has significant implications for the development of next-generation biopharmaceuticals. Through his adept application of molecular cloning techniques and high-throughput automation, Guy is at the forefront of optimizing bacterial strains for enhanced protein expression and therapeutic efficacy.
In his role, Guy is leading key projects that involve the design and implementation of advanced assay development methodologies. His proficiency in glycobiology and real-time polymerase chain reaction (qPCR) enables him to meticulously analyze and validate the performance of engineered strains, ensuring they meet stringent industry standards. Additionally, his hands-on experience with Western blotting and microscopy allows for precise characterization of protein products, further enhancing the quality and reliability of the biotherapeutics being developed.
As a team leader, Guy fosters a collaborative environment that encourages innovation and knowledge sharing among his colleagues. His commitment to advancing the field of life sciences is evident in his strategic approach to problem-solving and his ability to navigate complex scientific challenges. With a passion for pushing the boundaries of what is possible in biotechnology, Guy Bushkin is not only contributing to the success of Ancilia Biosciences but also shaping the future of therapeutic development through his groundbreaking work in bacterial engineering.
